Delivery Order SPE2DB22D1106-SPE2DB25FEYM7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $20,559.12. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,774.99 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical used...
- The U.S. Department of Defense Medical Supply Chain awarded a $2,701.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Phytonadione 10 mg/ml ampules, with an ultimate completion date of August 4, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,811.29 delivery order contract is for the supply of Phytonadione 10 mg/mL ampoules, a type of injectable vitamin K medication. The contract is not set aside and is a firm fixed-price agreement with a performance period through June 26, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Phytonadione 1 mg/0.5 mL syrup, a Vitamin K medication, with a ceiling value of $11,567.66 and a performance period ending on August 27, 2024. The contract is a firm fixed-price delivery order, and no set-aside designation was used. AmerisourceBergen, through its corporate office division, is the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Vitamin K-1 10 mg/ml ampules, with a contract ceiling value of $8,170.26. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The award carries no set-aside designation, indicating competitive procurement. Performance...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,548.82, is for the delivery of Phytonadione 1 mg/0.5 ml syrup, a medication used in the treatment of vitamin K deficiency. The contract has an ultimate completion date of December 11, 2024 and is a firm fixed-price delivery order. There is no set-aside designation for this award. AmerisourceBergen...
- This is a $1,903.20 firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of the drug Phytonadione 1 mg/0.5 ml syringe with a completion date of July 16, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,060,794 units of the medication Phytonadione 1 mg/0.5 ml syringe, with a ceiling value of $8,647.82. The award has an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a $4,352.86 firm fixed-price delivery order awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1 mg/0.5 mL syringes of phytonadione (vitamin K1). The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle. This non-set-aside contract allows for multiple...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEYM7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes valued at $2,716.90, with completion targeted for July 21, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical used in military and federal healthcare settings for coagulation management and blood clotting disorders. AmerisourceBergen Drug Corp has demonstrated significant capability to fulfill federal medical procurement requirements through its extensive portfolio of pharmaceutical deliveries to the Defense Logistics Agency and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's track record includes managing both small-value transactions and substantial orders exceeding $45,000, with consistent competitively awarded contracts reflecting its qualification to meet rigorous federal procurement standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/18/25 |